Our results now show that even in patients with a suggestive clinical scenario (1-5) and elevated IGF-1 (> 1.2 x ULN in some), confirmed in a second measurement and without apparent cause, acromegaly is very unlikely in the case of GH suppression in the OGTT. This evidence concerns the gene GH1 and acromegaly.